The U.S. Department of Justice (DOJ) has proposed a rule to reschedule marijuana from Schedule I to Schedule III under the Controlled Substances Act (CSA). This move, expected to be finalized by October, aims to ease restrictions on cannabis research and potentially reduce costs associated with studying the drug. The Drug Enforcement Administration (DEA) has confirmed the proposed change, which could have significant implications for the cannabis industry and scientific research. DEA Official stated that the rescheduling is anticipated to address long-standing barriers to marijuana research and may lead to more comprehensive studies on its effects and benefits.